Certificate record
Retatrutide, lot AS-RT30-3
ILS Laboratories assayed lot AS-RT30-3 of Retatrutide from Ascend Science at 99.9% purity on 10 Jun 2026, reporting 30.74 mg against a 30 mg label, 2.5% above the labelled mass.
Assayed 10 Jun 2026 · ILS Laboratories · Ascend Science · record id coa-www-as-rt30-3
What the certificate reports
| Compound | Retatrutide |
|---|---|
| Lot identifier | AS-RT30-3 |
| Purity | 99.9% |
| Labelled mass | 30 mg |
| Assayed mass | 30.74 mg |
| Difference | 2.5% above the label |
| Assay date | 10 Jun 2026 |
| Testing laboratory | ILS Laboratories |
| Who commissioned it | Published by the vendor. Scored as a claim, not as corroboration — only an independently commissioned assay counts as verified. |
| Source document | https://www.ascend.science/product/glp-3-rt |
Check it yourself
You do not have to trust this page, or the vendor. ILS Laboratories publishes its own lookup, so the report can be pulled from the laboratory directly.
Every ILS certificate carries a 7–8 character access code beneath the QR code in its header. Enter it on the laboratory’s verify page, or scan the code, and the report comes back from the laboratory’s own database.
Open the ILS Laboratories lookup and compare what it returns against the figures above. If the two disagree, the laboratory is right and we want to hear about it.
A certificate describes the sample it names and nothing else. It is not a statement about any other lot, and it is not an endorsement of the vendor or of any use of the material.
Other lots from Ascend Science
- Semaglutide, lot AS-SEMA10 99.73% · 25 Sept 2026
- MOTS-c, lot AS-MS20-2 99.91% · 24 Sept 2026
- Sermorelin, lot AS-SERM5-2 99.73% · 1 Sept 2026
- NAD+, lot AS-NAD1000-3 99.84% · 1 Sept 2026
- Tirzepatide, lot AS-TZ10-2 99.83% · 24 Aug 2026
- Tesamorelin, lot AS-TSM5-2 99.48% · 24 Aug 2026
Retatrutide from other vendors
- Origin Labs, lot Orig2609160091 99.82% · Freedom Diagnostics Testing
- Bench Grade Peptides, lot 00011/0011 99.8% · AV Analytics
- Bench Grade Peptides, lot 00011/0011 99.8% · AV Analytics
- Vial Drop Labs, lot VDL-20260827-8E2R 99.99% · KMD Analytical (KMD Group LLC)
- Vial Drop Labs, lot VDL-20260827-8VYD 99.98% · KMD Analytical (KMD Group LLC)
- Next Gen Peptides, lot RT20-12 99.7% · ILS Laboratories